相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury
Qing-Sheng Li et al.
NEURAL REGENERATION RESEARCH (2023)
Drug Metabolism: A Half-Century Plus of Progress, Continued Needs, and New Opportunities
F. Peter Guengerich
DRUG METABOLISM AND DISPOSITION (2023)
Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs
Vanessa Steenkamp et al.
THERAPEUTIC DRUG MONITORING (2023)
Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D6*17 Variant on the Formation of the Active Metabolite, Endoxifen
Comfort Ropafadzo Kanji et al.
JOURNAL OF PERSONALIZED MEDICINE (2023)
Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy
Ragini D. D. Singh et al.
ANTIOXIDANTS & REDOX SIGNALING (2023)
The Evolution of Drug Metabolism and Disposition: A Perspective From the Editors
Edward T. Morgan et al.
DRUG METABOLISM AND DISPOSITION (2023)
COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics
Eliza R. Mccoll et al.
DRUG METABOLISM AND DISPOSITION (2023)
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations
Chiea Chuen Khor et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4 and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitro
Marie-Noeurolle Paludetto et al.
DRUG METABOLISM AND DISPOSITION (2023)
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
Ellen Q. Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Enzyme Activity of Natural Products on Cytochrome P450
Hua-Li Zuo et al.
MOLECULES (2022)
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Alessia Catalano et al.
MOLECULES (2022)
ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites
Alejandra Martinez-Chavez et al.
PHARMACOLOGICAL RESEARCH (2022)
Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9
Elodie Goldwaser et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole
Zhelong Liu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy
Guyi Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Association of P450 Oxidoreductase Gene Polymorphism with Tacrolimus Pharmacokinetics in Renal Transplant Recipients: A Systematic Review and Meta-Analysis
Da-Hoon Lee et al.
PHARMACEUTICS (2022)
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy
Gabriel Hancu et al.
PHARMACEUTICALS (2022)
Cytochrome P450 reductase gene, POR, associated with paclitaxel induced peripheral neuropathy in patients of European ancestry from the adjuvant breast cancer trial, ECOG-ACRIN E5103
Fei Shen et al.
CANCER RESEARCH (2022)
Neutrophil Myeloperoxidase-Mediated N-Demethylation of Quetiapine Leads to N-Desalkylquetiapine, a Pharmacologically Active Cytochrome P450 Metabolite
Md Harunur Rashid et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2022)
Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals
Xiaoxing Wang et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2022)
Alcohol intoxication stimulates antioxidant gene expression in skeletal muscle in a time dependent manner
Abigail L. Tice et al.
FASEB JOURNAL (2022)
A Comprehensive Investigation of Interactions between Antipsychotic Drug Quetiapine and Human Serum Albumin Using Multi-Spectroscopic, Biochemical, and Molecular Modeling Approaches
Seema Zargar et al.
MOLECULES (2022)
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
Domenico Iacopetta et al.
VIRUSES-BASEL (2022)
Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment
Paulina Wigner et al.
NUTRIENTS (2022)
New Achievements for the Treatment of Triple-Negative Breast Cancer
Alessia Catalano et al.
APPLIED SCIENCES-BASEL (2022)
Drugs for COVID-19: An Update
Jessica Ceramella et al.
MOLECULES (2022)
Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022
Terry D. Hinds et al.
FRONTIERS IN PHARMACOLOGY (2022)
Molecular Modeling of Cardiac Sodium Channel with Mexiletine
Boris S. S. Zhorov
MEMBRANES (2022)
Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo
Yiran Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse
Yusuke Motoji et al.
BIOMEDICINES (2022)
Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis
Yoshimasa Nobeyama et al.
JOURNAL OF DERMATOLOGY (2022)
Use of low-dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator-controlled cohort study
Mikkel Hojlund et al.
WORLD PSYCHIATRY (2022)
A Look at the Importance of Chirality in Drug Activity: Some Significative Examples
Jessica Ceramella et al.
APPLIED SCIENCES-BASEL (2022)
Molecular probes for human cytochrome P450 enzymes: Recent progress and future perspectives
Jingjing Wu et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment
Liang Dai et al.
FRONTIERS IN PHARMACOLOGY (2021)
Diarylureas as Antitumor Agents
Alessia Catalano et al.
APPLIED SCIENCES-BASEL (2021)
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
Alessia Catalano et al.
ANTIBIOTICS-BASEL (2021)
Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasma
Sakambari Tripathy et al.
BIOANALYSIS (2021)
The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
Yang Xiao et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite
Pramod C. Nair et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
Ellen Q. Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27(kip1) Axis
Xin Zhou et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
The Different Facets of Triclocarban: A Review
Domenico Iacopetta et al.
MOLECULES (2021)
Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer
Thomas Helland et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Potential clinically significant drug-drug interactions of hydroxychloroquine used in the treatment of COVID-19
Mohitosh Biswas et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
F/G Region Rigidity is Inversely Correlated to Substrate Promiscuity of Human CYP Isoforms Involved in Metabolism
Daniel Becker et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC-MS/MS
Alejandra Martinez-Chavez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Sonlicromanol's active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth
Xiaolan Jiang et al.
PLOS ONE (2021)
Association between CYP3A5 Polymorphism and Statin-Induced Adverse Events: A Systemic Review and Meta-Analysis
Jeong Yee et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
Brendan Le Dare et al.
CRITICAL CARE (2021)
A history of the roles of cytochrome P450 enzymes in the toxicity of drugs
F. Peter Guengerich
TOXICOLOGICAL RESEARCH (2021)
Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress
Vivian Lee et al.
EXPERIMENTAL DERMATOLOGY (2020)
Clinically relevant drug interactions between statins and antidepressants
Caterina Palleria et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
mRNA levels of drug-metabolizing enzymes in 11 brain regions of cynomolgus macaques
Yasuhiro Uno et al.
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
Richard Myles Turner et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
Yiran Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
Carmen W. H. Chan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Fate, risk and removal of triclocarban: A critical review
Hui Yun et al.
JOURNAL OF HAZARDOUS MATERIALS (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer
P. Kellie Turner et al.
DRUG METABOLISM AND DISPOSITION (2020)
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Jonathan Silverberg et al.
JAMA DERMATOLOGY (2020)
Triclocarban-induced responses of endogenous and xenobiotic metabolism in human hepatic cells: Toxicity assessment based on nontargeted metabolomics approach
Hongna Zhang et al.
JOURNAL OF HAZARDOUS MATERIALS (2020)
The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A > G Spectrum Disorders
Mirian C. H. Janssen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management
Kim M. Blakely et al.
DRUG SAFETY (2019)
Identification of bioactive metabolites using activity metabolomics
Markus M. Rinschen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4-Hydroxycholesterolan Interaction Study in Healthy Volunteers
Caroline Gjestad et al.
AAPS JOURNAL (2019)
Functional expression and activity screening of all human cytochrome P450 enzymes in fission yeast
Pradeepraj Durairaj et al.
FEBS LETTERS (2019)
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism
Josefine Schulz et al.
DRUG METABOLISM REVIEWS (2019)
Development and validation of a volumetric absorptive microsampling assay for analysis of voriconazole and voriconazole N-oxide in human whole blood
Ganesh S. Moorthy et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Molecularly imprinted hydrogels for sustained release of sunitinib in breast cancer therapy
Luca Scrivano et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2019)
Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism
Nirav D. Patel et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib
Gracia M. Amaya et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Palrasu Manikandan et al.
CURRENT DRUG TARGETS (2018)
Update on the Use of Vonoprazan: A Competitive Acid Blocker
David Y. Graham et al.
GASTROENTEROLOGY (2018)
Electrochemical simultaneous determination of nifedipine and its main metabolite dehydronifedipine using MWCNT modified glassy carbon electrode
Banafsheh Mokhtari et al.
JOURNAL OF MOLECULAR LIQUIDS (2018)
Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort
Richard Myles Turner et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
Kentaro Sugano
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery
Julien Beyrath et al.
SCIENTIFIC REPORTS (2018)
Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits
Slobodan P. Rendic et al.
DRUG METABOLISM REVIEWS (2018)
Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
Jarrett R. Amsden et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers
Sunny Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers
Saskia Koene et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
PharmGKB summary: voriconazole pathway, pharmacokinetics
Julia M. Barbarino et al.
PHARMACOGENETICS AND GENOMICS (2017)
The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
Hirotoshi Echizen
CLINICAL PHARMACOKINETICS (2016)
Quantum Mechanics/Molecular Mechanics Modeling of Drug Metabolism: Mexiletine N-Hydroxylation by Cytochrome P450 1A2
Richard Lonsdale et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
A validated simultaneous quantification method for vonoprazan (TAK-438F) and its 4 metabolites in human plasma by the liquid chromatography-tandem mass spectrometry
Tomoki Yoneyama et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?
Tzu-Fei Wang et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism
Timothy S. Tracy et al.
DRUG METABOLISM AND DISPOSITION (2016)
The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity
Janne Hukkanen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Vonoprazan: First Global Approval
Karly P. Garnock-Jones
DRUGS (2015)
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals
Slobodan Rendic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Evaluation of 89 Compounds for Identification of Substrates for Cynomolgus Monkey CYP2C76, a New Bupropion/Nifedipine Oxidase
Shinya Hosaka et al.
DRUG METABOLISM AND DISPOSITION (2015)
Metabolic Activation of the Antibacterial Agent Triclocarban by Cytochrome P450 1A1 Yielding Glutathione Adducts
Nils Helge Schebb et al.
DRUG METABOLISM AND DISPOSITION (2014)
Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(-) electrospray tandem mass spectrometry
Pankaj Partani et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2014)
Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence
Nuggehally R. Srinivas
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2013)
PharmGKB summary: tamoxifen pathway, pharmacokinetics
Daniel J. Klein et al.
PHARMACOGENETICS AND GENOMICS (2013)
Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions
Yoshiyuki Shirasaka et al.
DRUG METABOLISM AND DISPOSITION (2013)
Synthesis and Toxicopharmacological Evaluation of m-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels
Alessia Catalano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans
Bill Speed et al.
DRUG METABOLISM AND DISPOSITION (2012)
Electrochemistry-Mass Spectrometry Unveils the Formation of Reactive Triclocarban Metabolites
A. Baumann et al.
DRUG METABOLISM AND DISPOSITION (2010)
Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5
Gry Vibeke Bakken et al.
DRUG METABOLISM AND DISPOSITION (2009)
Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements
Kouichi Yoshinari et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Quetiapine and drug interactions: Evidence from a routine therapeutic drug monitoring service
Ingrid Castberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents
M. De Bellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Enantiomer/enantiomer interactions between the S- and R-isomers of omeprazole in human cytochrome P450 enzymes:: Major role of CYP2C19 and CYP3A4
XQ Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Grapefruit juice-nifedipine interaction:: possible involvement of several mechanisms
P Odou et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia
KY Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Stereospecific synthesis of para-hydroxymexiletine and sodium channel blocking activity evaluation
A Catalano et al.
CHIRALITY (2004)
Food-drug interaction: grapefruit juice augments drug bioavailability - mechanism, extent and relevance
A Dahan et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2004)
Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice
ML Veronese et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Voriconazole: A new triazole antifungal agent
LB Johnson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile
A De Luca et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
Esomeprazole: A clinical review
TJ Johnson et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2002)
Effect of oral ketoconazole on first-pass effect of nifedipine after oral administration in dogs
M Kuroha et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
LB Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)